IPO Boutique

Third Harmonic Bio, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Third Harmonic Bio, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Third Harmonic Bio, Inc.THRD -
NASDAQ
$16.00-$18.00 $17.00 $20.5010.9 million9/15/2022
Morgan Stanley, Jefferies, Cowen
Co-Manager(s):
LifeSci Capital
Health Care
Filing(s):

Filed 2022-08-23
Terms Added 2022-09-08



Third Harmonic Bio, Inc. Quote & Chart - Click for current quote - THRD

About Third Harmonic Bio, Inc. (adapted from Third Harmonic Bio, Inc. prospectus):
They are a clinical-stage biopharmaceutical company focused on the development of the next wave of medicine for the treatment of allergic and inflammatory diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "THRD" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved